-
1 Comment
Zhongzhu Healthcare Holding Co.,Ltd is currently in a long term uptrend where the price is trading 23.3% above its 200 day moving average.
From a valuation standpoint, the stock is 57.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Zhongzhu Healthcare Holding Co.,Ltd's total revenue rose by 19.8% to $178M since the same quarter in the previous year.
Its net income has increased by 63.0% to $-15M since the same quarter in the previous year.
Finally, its free cash flow fell by 2.5% to $96M since the same quarter in the previous year.
Based on the above factors, Zhongzhu Healthcare Holding Co.,Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE0000017X8 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.34 |
|---|---|
| PE Ratio | None |
| Target Price | 12.5 |
| Market Cap | 3B |
| Dividend Yield | None |
Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzazole Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in production and sales of products of hepatest ultrasonic liver cirrhosis detector, infusion heater, and Moon God whole body gamma knife. In addition, the company develops 1.1-class chemical drug Leonurine (SCM-198) project with the effect of lowering blood lipids and preventing and treating stroke; and genistein capsules for the treatment of osteoporosis. Further, it engages in residential real estate development; business management; hospital investment management; technology promotion and application services; research and experimental development; special equipment manufacturing industry; and financial leasing business. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co., Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Zhuhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600568.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
